4//SEC Filing
TearLab Corp 4
Accession 0001437749-13-013051
CIK 0001299139operating
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 2:27 PM ET
Size
8.6 KB
Accession
0001437749-13-013051
Insider Transaction Report
Form 4
TearLab CorpTEAR
Karpecki Paul
Director
Transactions
- Exercise/Conversion
Common Stock
2013-10-11$3.12/sh+5,000$15,600→ 8,500 total - Sale
Common Stock
2013-10-11$10.96/sh−5,000$54,819→ 3,500 total - Exercise/Conversion
Stock Option (right to buy)
2013-10-11−5,000→ 3,376 totalExercise: $3.12Exp: 2018-12-12→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on April 2, 2013.
- [F2]Represents the weighted average share price of an aggregate total of 5,000 shares sold in the price range of $10.905 to $11.02 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F3]Twenty-five percent (25%) of the shares subject to the option vested and became exercisable on April 12, 2010, and, thereafter, one thirty sixth (1/36th) of the remaining shares subject to the option vested and became exercisable in equal monthly installments over the next thirty six (36) months.
Documents
Issuer
TearLab Corp
CIK 0001299139
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001299139
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 2:27 PM ET
- Size
- 8.6 KB